Physician profile
John Peter Pirris
NPI 1215939400
$639,909.05
in general payments reported to CMS, 2019-2025
29 companies · $64K in 2025
The $64K reported for 2025 was more than what 98% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96K · 2020: $105K · 2021: $2,366 · 2022: $115K · 2023: $113K · 2024: $145K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $289K · Education: $13K · Food and Beverage: $13K · Travel and Lodging: $5,258 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $289,196.32 |
| Education | $13,400.00 |
| Food and Beverage | $13,083.20 |
| Travel and Lodging | $5,257.58 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $602,093.37 | 2019-2025 | Sternalock 360 System, Sternalock Blu System, Advantagerib |
| Baxter Healthcare | $15,171.18 | 2024-2025 | Coseal, Hemopatch, Floseal |
| Abiomed | $4,105.51 | 2022-2025 | Impella |
| Team 1, LLC | $3,684.29 | 2023-2025 | |
| Elutia, INC. | $3,523.83 | 2019-2023 | |
| Medtronic, INC. | $2,011.62 | 2022-2025 | Penditure, Avalus, Corevalve Evolut R |
| Abbott Laboratories | $1,769.20 | 2020-2025 | Epic, Mitraclip, Navitor |
| Edwards Lifesciences Corporation | $1,759.46 | 2021-2025 | Konect Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $1,689.59 | 2022-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Artivion, INC. | $1,016.82 | 2022-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Vb Spine LLC | $912.19 | 2025 | Monterey Al, Niagara Lateral Access System |
| Livanova USA, INC. | $449.46 | 2019-2023 | Tandemlife, Lifesparc |
| Arthrex, INC. | $326.65 | 2024 | |
| Philips North America LLC | $253.06 | 2023-2025 | Laser Parts Other |
| Getinge USA Sales, LLC | $247.60 | 2022-2025 | Cardiohelp, Vasoview Hemopro 2, Vasoview Hemopro 2 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $178.96 | 2020 | |
| W. L. Gore & Associates, INC. | $156.69 | 2024-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Ethicon US, LLC | $153.77 | 2025 | Evarrest, Vistaseal, Surgiflo Hemostatic Matrix |
| Acell, INC. | $73.34 | 2020 | |
| Clearflow INC. | $69.39 | 2024 | Pleuraflow System With Flowglide |
| Lsi Solutions INC | $56.92 | 2022-2025 | Minirumel, Cor-Knot |
| Bolton Medical INC | $45.33 | 2022-2024 | Treo Abdominal Stent-Graft System |
| Sanara Medtech INC. | $45.12 | 2024 | Celleraterx |
| Convatec INC. | $25.20 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $23.44 | 2023 | Imfinzi |
| Pacira Pharmaceuticals Incorporated | $19.56 | 2024 | Exparel |
| Lemaitre Vascular, INC. | $17.75 | 2023 | Tyke, Patch, Pledget and Intracardiac |
| Janssen Pharmaceuticals, INC | $16.61 | 2023 | Xarelto |
| Hikma Pharmaceuticals USA | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pirris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.